Significantly lower risk is seen for ICU admission, hospitalization, recovery, and viral clearance. 3 studies from 3 independent teams (all from the same country) show significant benefit.
Meta analysis using the most serious outcome reported shows 38% [20‑51%] lower risk. Results are similar for Randomized Controlled Trials.
No treatment is 100% effective. Protocols combine safe and effective options with individual risk/benefit analysis and monitoring. Other treatments are more effective. Phthalocyanine may affect the natural microbiome, especially with prolonged use. All data and sources to reproduce this analysis are in the appendix.
Covid Analysis et al., May 2025, preprint, 1 author.
